Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-01

Clinical Trial Update: Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating fecal microbiome transplantation for decompensated cirrhosis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiome transplantation

Snippet

Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER) | Conditions: Decompensated Cirrhosis | Phase 3 | Status: NOT_YET_RECRUITING